Sabrina Simoes

Sabrina Simoes

Auto-generated profile, based on publicly available information

Sabrina Simoes

Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY 10032, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Cell Reports
Verified
Journal Article
Open access
SSSabrina Simoes
Sabrina Simoes
JGJia Guo
Jia Guo
LBLuna Buitrago
Luna Buitrago
YQYasir H. Qureshi
Yasir H. Qureshi
XFXinyang Feng
Xinyang Feng
SSScott A. Small
Scott A. Small
Whether and how the pathogenic disruptions in endosomal trafficking observed in Alzheimer’s disease (AD) are linked to its anatomical vulnerability remain unknown. Here, we began addressing these questions by showing that neurons are enriched with a second retromer core, organized around VPS26b, differentially dedicated to endosomal recycling. Next, by imaging mouse models, we show that the trans-entorhinal cortex, a region most vulnerable to AD, is most susceptible to VPS26b depletion—a finding validated by electrophysiology, immunocytochemistry, and behavior. VPS26b was then found enriched in the trans-entorhinal cortex of human brains, where both VPS26b and the retromer-related receptor SORL1 were found deficient in AD. Finally, by regulating glutamate receptor and SORL1 recycling, we show that VPS26b can mediate regionally selective synaptic dysfunction and SORL1 deficiency. Together with the trans-entorhinal’s unique network properties, hypothesized to impose a heavy demand on endosomal recycling, these results suggest a general mechanism that can explain AD’s regional vulnerability.

25 November 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
SSSabrina Simoes
Sabrina Simoes
JNJessica L. Neufeld
Jessica L. Neufeld
GTGallen Triana-Baltzer
Gallen Triana-Baltzer
SMSetareh Moughadam
Setareh Moughadam
ECEmily I. Chen
Emily I. Chen
SSScott A. Small
Scott A. Small
Endosomal secreted proteins can be detected in the CSF and inform on how Alzheimer’s defective trafficking pathway can contribute to disease spread.

19 February 2024 in Philosophical Transactions of the Royal Society B: Biological Sciences
Verified
Journal Article
Open access
MHMathieu Herman
Mathieu Herman
GRGrace W. Randall
Grace W. Randall
JSJulia L. Spiegel
Julia L. Spiegel
DMDelphina J. Maldonado
Delphina J. Maldonado
SSSabrina Simoes
Sabrina Simoes
Over the past two decades, increased research has highlighted the connection between endosomal trafficking defects and neurodegeneration. The endo-lysosomal network is an important, complex cellular system specialized in the transport of proteins, lipids, and other metabolites, essential for cell homeostasis. Disruption of this pathway is linked to a wide range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and frontotemporal dementia. Furthermore, there is strong evidence that defects in this pathway create opportunities for diagnostic and therapeutic intervention. In this Opinion piece, we concisely address the role of endo-lysosomal dysfunction in five neurodegenerative diseases and discuss how future research can investigate this intracellular pathway, including extracellular vesicles with a specific focus on exosomes for the identification of novel disease biomarkers. This article is part of a discussion meeting issue ‘Understanding the endo-lysosomal network in neurodegeneration’.